Animal studies on oral mesalazine do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Salofalk should only be used during pregnancy if the potential benefit outweighs the possible risk.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
